Gastrointestinal Bleeding Treatment Devices Market Share, Size, Trends Report 2024-2033


Posted December 28, 2023 by BharadwajReddy

Global gastrointestinal bleeding treatment devices market size is expected to reach $1.2 Bn by 2028 at a rate of 7.6% segmented as by product, endoscopic thermal devices, other products

 
The Gastrointestinal Bleeding Treatment Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Gastrointestinal Bleeding Treatment Devices Market:
https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

According to The Business Research Company’s Gastrointestinal Bleeding Treatment Devices Global Market Report 2024, The gastrointestinal bleeding treatment devices market size has grown strongly in recent years. It will grow from $0.84 billion in 2023 to $0.9 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to aging population, lifestyle factors, healthcare infrastructure, gastrointestinal disorders, endoscopy advances.

The gastrointestinal bleeding treatment devices market size is expected to see strong growth in the next few years. It will grow to $1.2 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to patient-centric care, regulatory changes, telemedicine and remote consultations, increasing gastrointestinal disorders, healthcare investment. Major trends in the forecast period include non-invasive diagnostic technologies, non-invasive diagnostic technologies, precision medicine, remote monitoring and telehealth, artificial intelligence and machine learning.

The rise in the incidences of upper gastrointestinal bleeding is likely to contribute to the growth of the gastrointestinal bleeding treatment devices market during the forecast period. The upper gastrointestinal (GI) bleeding occurs in the esophagus, the stomach, or the upper part of the small intestine and can be caused due to peptic ulcers, esophagitis, enteritis, gastritis, cancer, and other reasons. For instance, according to the National Institute for Health and Care Excellence, in the UK the incidence of acute upper GI bleeding ranges from 84-172 per 100,000 of the population per year. Furthermore, as per the study published in National Library of Medicine - National Institutes of Health in 2023, in-hospital mortality rates for upper GI bleeds stand at approximately 10%. This rate remains consistent up to one month following hospitalization for GI bleed. Over the long term, three years after admission, mortality rates from all causes reach nearly 37%.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=5307&type=smp

The gastrointestinal bleeding treatment devices market covered in this report is segmented –

1) By Product: Endoscopic Thermal Devices, Other Products
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users

The increasing number of product approvals is the key trend gaining popularity in the gastrointestinal bleeding treatment devices market. Key players in the market are focusing on product approvals to maintain a comparative advantage over competitors in the industry. For example, in February 2021, EndoClot Plus Inc., a US-based company developing medical devices to meet the needs of the GI professional announced U.S. Food and Drug Administration (FDA) approval for EndoClot Polysaccharide Hemostatic System (EndoClot PHS), which is an advanced product that will assist Gastroenterologists to stop bleeding quickly and effectively. EndoClot PHS is a one-time-use device that consists of a starch-based powder hemostat that is applied directly to the bleeding location using a flexible endoscope.

The gastrointestinal bleeding treatment devices market report table of contents includes:

1. Executive Summary

2. Gastrointestinal Bleeding Treatment Devices Market Characteristics

3. Gastrointestinal Bleeding Treatment Devices Market Trends And Strategies

4. Gastrointestinal Bleeding Treatment Devices Market - Macro Economic Scenario

5. Global Gastrointestinal Bleeding Treatment Devices Market Size and Growth

...

31. Global Gastrointestinal Bleeding Treatment Devices Market Competitive Benchmarking

32. Global Gastrointestinal Bleeding Treatment Devices Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Gastrointestinal Bleeding Treatment Devices Market

34. Gastrointestinal Bleeding Treatment Devices Market Future Outlook and Potential Analysis

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By TBRC
Country United States
Categories Business
Last Updated December 28, 2023